Given that subtle cognitive decline might start in late middle age, we also explored which biomarkers predicted lower episodic memory performance in this cohort and found that the classical AD biomarkers, Aβ and tau, did not significantly associate with lower episodic memory. The gene discussed is MAPT; the disease is Alzheimer disease.